双极皮肤内心隔膜膜的射频切除 (Bi-PESA):这是首次在人体中用于高伤性阻塞性心肌病的应用
Aiju Tian1, Yuhe Jia1, Minghu Xiao2
1Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
JACC. Case reports
|December 3, 2025
概括
双极和皮肤穿透性内心隔膜放射频移除 (Bi-PESA) 组合提供了一种针对药物耐药性缩性阻塞性心肌病 (HOCM) 的新疗法. 这种新的方法有效地减少了左心室外流通道梯度,并改善了患者的症状.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗技术 医疗技术 医学技术
背景情况:
- 药物耐药性缩性阻塞性心肌病 (HOCM) 对那些不适合手术或酒精隔膜切除的患者提出了治疗挑战.
- 传统的单极无线电频率切除由于病变深度不深,因此提供有限的缓解.
- 对心室心律失常有效的双极射频切除,尚未被用于HOCM.
研究的目的:
- 报告人类首次应用双极性和皮肤内心隔膜放射频移除 (Bi-PESA) 联合治疗耐药HOCM.
- 评估Bi-PESA在减少左心室外流通道梯度 (LVOTG) 和改善症状方面的疗效.
主要方法:
- 一种新的综合技术,Bi-PESA,在一个患有药物耐药HOCM的老年患者身上进行.
- 该程序的目的是创建比传统方法更深的隔膜病变.
主要成果:
- 在Bi-PESA手术后,患者的LVOTG显著减少.
- 干预后观察到显著的症状改善.
结论:
- 双PESA代表了一种新,有效和安全的隔膜缩小疗法,用于HOCM.
- 这种技术可能是HOCM患者的可行和可取的替代方案,因为他们无法接受或拒绝传统治疗.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
01:29Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314